- Concomitant use of vasoconstricting agents for the purpose of increasing BP such as ephedrine, dihydroergotamine, or midodrine must stop taking these drugs at least 2 days or five half-lives (whichever is longer) prior to dosing on Day 1 and throughout the duration of the study.